The Medicines Company Surrenders Early Gains After FDA Approval Of Vabomere

By: via Benzinga
The Medicines Company (NASDAQ: MDCO) shares are trading lower by $1.36 (3.5 percent) at $37.38 in Wednesday's session. Before the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.